{"schema_version":"secwatch.filing_event.v1","accession":"0001964738-24-000040","form_type":"8-K","ticker":"SOLV","cik":"0001964738","company_name":"Solventum Corp","filed_at":"2024-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.458312+00:00","generated_at":"2026-05-30T03:57:40.089595+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Solventum Q3 sales flat at $2.082B; adjusted EPS $1.64, raises FY guidance","bullets":["GAAP EPS $0.70, adjusted EPS $1.64; operating income $275M GAAP, $475M adjusted.","Reported sales +0.4% YoY; organic sales +0.3%; MedSurg and HIS led growth.","Free cash flow $76M; cash from operations $169M.","Full-year organic sales growth, adjusted EPS, and free cash flow guidance raised.","CEO cites consecutive outperformance; supply agreement mark-up impacted margins."],"urls":{"canonical":"https://secwatch.observer/filing/0001964738-24-000040","json":"https://secwatch.observer/filing/0001964738-24-000040.json","markdown":"https://secwatch.observer/filing/0001964738-24-000040.md","text":"https://secwatch.observer/filing/0001964738-24-000040.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1964738/000196473824000040/0001964738-24-000040-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1964738/000196473824000040/solv-20241107.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T03:57:40.089595+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}